1-3 of 3
Anthony R. Green, MD, PHD
Close
Sort by
Journal Articles

Collaboration between Activating Mutations in JAK2 and Trisomy 21 in the Acute Lymphoblastic Leukemias of Down Syndrome (DS).

Ithamar Ganmore, Dan Bercovich, PhD, Linda M. Scott, PhD, Anthony R. Green, MD PhD, Giovanni Cazzaniga, PhD, Andrea Biondi, MD, Giuseppe Basso, MD, Gunnar Cario, MD, Martin Schrappe, MD, Martin Stanulla, MD PhD, Sabine Strehl, PhD, Oskar A. Haas, MD, Vera Binder, MD, Arndt Borkhardt, MD, Jan Trka, MD, Bella Bielorei, MD, Smadar Avigad, PhD, Batia Stark, MD, Jean-Pierre Bourquin, MD, Owen Smith, MD, Helena Kempski, PhD, Shai Izraeli, MD
Journal: Blood
Blood (2007) 110 (11): LB6.
https://doi.org/10.1182/blood.V110.11.LB6.lb6
Published: 2007
Journal Articles

Reversible Expansion of Hematopoietic Stem Cells (HSC) and CML-Like Disease in Transgenic Mice Expressing BCR-ABL under the Control of the SCL 3′ Enhancer.

Steffen Koschmieder, MD, Berthold Goettgens, PHD, Pu Zhang, MD, Tajhal Dayaram, Kristin Geary, Anthony R. Green, MD, PHD, Daniel G. Tenen, MD, Claudia S. Huettner, PHD
Journal: Blood
Blood (2004) 104 (11): 715.
https://doi.org/10.1182/blood.V104.11.715.715
Published: 2004
Journal Articles

An SCL +19 Core Enhancer Targets Three Mesoderm-Derived Cell Lineages - Blood, Endothelium and Smooth Muscle.

Lev Silberstein, MD, Maria Jose Sanchez, PhD, Merav Socolovsky, MD, PhD, Gary J. Hoffman, MD, Sandie Piltz, Mark Bowen, Anthony R. Green, MD, PhD, Berthold Gottgens, PhD
Journal: Blood
Blood (2004) 104 (11): 4200.
https://doi.org/10.1182/blood.V104.11.4200.4200
Published: 2004